全文获取类型
收费全文 | 13189篇 |
免费 | 1047篇 |
国内免费 | 51篇 |
专业分类
耳鼻咽喉 | 107篇 |
儿科学 | 408篇 |
妇产科学 | 297篇 |
基础医学 | 1965篇 |
口腔科学 | 110篇 |
临床医学 | 1395篇 |
内科学 | 2912篇 |
皮肤病学 | 260篇 |
神经病学 | 1441篇 |
特种医学 | 357篇 |
外国民族医学 | 6篇 |
外科学 | 1588篇 |
综合类 | 51篇 |
现状与发展 | 1篇 |
一般理论 | 7篇 |
预防医学 | 930篇 |
眼科学 | 247篇 |
药学 | 913篇 |
中国医学 | 11篇 |
肿瘤学 | 1281篇 |
出版年
2024年 | 25篇 |
2023年 | 156篇 |
2022年 | 261篇 |
2021年 | 548篇 |
2020年 | 347篇 |
2019年 | 498篇 |
2018年 | 479篇 |
2017年 | 378篇 |
2016年 | 381篇 |
2015年 | 434篇 |
2014年 | 584篇 |
2013年 | 678篇 |
2012年 | 1057篇 |
2011年 | 1058篇 |
2010年 | 579篇 |
2009年 | 436篇 |
2008年 | 781篇 |
2007年 | 779篇 |
2006年 | 720篇 |
2005年 | 767篇 |
2004年 | 647篇 |
2003年 | 565篇 |
2002年 | 500篇 |
2001年 | 150篇 |
2000年 | 122篇 |
1999年 | 146篇 |
1998年 | 125篇 |
1997年 | 101篇 |
1996年 | 73篇 |
1995年 | 68篇 |
1994年 | 48篇 |
1993年 | 45篇 |
1992年 | 61篇 |
1991年 | 52篇 |
1990年 | 54篇 |
1989年 | 61篇 |
1988年 | 39篇 |
1987年 | 61篇 |
1986年 | 40篇 |
1985年 | 48篇 |
1984年 | 47篇 |
1983年 | 27篇 |
1982年 | 19篇 |
1981年 | 19篇 |
1980年 | 23篇 |
1979年 | 26篇 |
1978年 | 22篇 |
1974年 | 14篇 |
1973年 | 14篇 |
1968年 | 13篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
Bertrand Dussol Cecilia Iovanna Denis Raccah Patrice Darmon Sophie Morange Philippe Vague Bernard Vialettes Charles Oliver Anderson Loundoun Yvon Berland 《Journal of renal nutrition》2005,15(4):398-406
OBJECTIVE: The efficacy of a low-protein diet in the secondary prevention of diabetic nephropathy is not established in patients with type 1 or type 2 diabetes mellitus. To determine whether a low-protein diet slows the decrease in glomerular filtration rate (GFR) and decreases the albumin excretion rate (AER) in diabetic patients with incipient and overt nephropathy, we performed a 2-year prospective, randomized controlled trial comparing the effects of a low-protein diet (0.8 g/kg/day) with a usual-protein diet. SETTING AND PATIENTS: The study was conducted in a University hospital and included 63 type 1 and type 2 diabetic patients with either incipient or overt nephropathy and mild renal failure (prestudy GFR, 80 +/- 20 mL/min). The primary outcome measures were decreased in GFR and 24-hour AER. RESULTS: In the low-protein-diet group, patients were younger (52 +/- 12 versus 63 +/- 9 years old) and more often were type 2 diabetic. During the follow-up period, according to dietary records the low-protein-diet group consumed 16% +/- 3% of total caloric intakes as compared with 19% +/- 4% in the usual-protein-diet group (P < .02), but 24-hour urinary urea excretions did not differ between the two groups. The 2-year GFR decrease was 7 +/- 11 mL/min in the low-protein-diet group and 5 +/- 15 mL/min in the usual-protein-diet group (P = not significant). AER did not increase significantly in the two diet groups during the follow-up period. Blood pressure and glycemic control were similar in the two groups all along the study. The decrease in GFR and AER were also similar in 6 compliant patients according to dietary records and to 24-hour urinary urea excretions from the low-protein-diet group and in 12 patients from the usual-protein-diet group. CONCLUSIONS: A 2-year low-protein diet did not alter the course of GFR or of AER in diabetic patients with incipient or overt nephropathy receiving renin-angiotensin blockers with strict blood pressure control. 相似文献
32.
33.
A One–Step, Operator–Independent Method for Isolating Islets of Langerhans from the Porcine Pancreas
Christophe Arbet–Engels Sylviane Darquy Frédérique Capron Maria E. Pueyo Sophie Dimaria Vincent Poitout Gérard Reach 《Artificial organs》1994,18(8):570-575
Abstract: Large–scale isolation of islets of Langerhans is one of the major obstacles in islet transplantation. Until now, isolation methods relied on enzymatic digestion, the duration of which relies on a decision dictated by the operator's experience. This approach has always hindered development of an automated method. The aim of this study was to develop a one–step method based on complete digestion of the pancreas. The original aspect of the technique (derived from the Ricordi method) is use of the University of Wisconsin (UW) solution in the digestion medium and a continuous flow collagenase processing circuit with local cooling and rewarming to allow tissue digestion to proceed at 37°C while settling of the cell suspension takes place at 4°C. A stopcock system permits the alternate use of two settling chambers so that while one is in the circuit, the other can be removed for cen–trifugation, resuspension of the crude islet preparation in collagenase in free UW solution, and further purification in a density gradient system. Ten experiments were performed, and 545, 750 ± 48, 670 purified pig islets were obtained per totally digested pancreas. Histological studies showed cell integrity. Insulin secretion in response to double glucose stimulation under perfusion conditions demonstrated the functional viability of the isolated islets. In conclusion, this one–step method makes it possible to obtain a high number of viable islets of Langerhans in the absence of any decision by an operator, and it should therefore provide basis for an automated method. 相似文献
34.
Randomised prospective study on renal effects of two different contrast media in humans: protective role of a calcium channel blocker 总被引:6,自引:0,他引:6
Contrast media affect renal hemodynamics. Hyperosmolality is regarded as the major factor responsible for renal hemodynamic changes. In this study, the role of osmolality was evaluated in 30 hospitalized patients without risk factors during intravenous pyelography. Contrast media with low and high osmolality were used. In addition, nifedipine was administered before infusion of high-osmolality contrast to evaluate the role of calcium ions in radiocontrast-induced changes of renal hemodynamics. Hyperosmolar contrast reduced renal plasma flow and glomerular filtration rate. Calcium channel blocker prevented changes of renal hemodynamics. Hyperosmolality appears the most likely factor affecting renal hemodynamics during hyperosmolar radiocontrast infusion. Calcium channel blocker may prevent renal changes due to hyperosmolar medium. 相似文献
35.
Residual damage in haemopoietic progenitor cell populations, spleen and granulocyte-macrophage colony-forming cells (CFU-S and GM-CFC) was detected in mice after 15 daily fractions where the dose per fraction was as low as 0.1 Gy. The injury was dose-dependent and after higher total fractionated doses of 7.5-10 Gy the CFU-S population recovered to about 50% of control between 2 and 12 months after irradiation. Residual damage was also detected in the stroma, in the form of reduced numbers of fibroblastoid colony-forming cells and of CFU-S in ossicles under the kidney capsule. The response to a second course of 15 fractions, given 3 weeks after the end of the first course, was similar and additive to the response to the first course in the short term. However, in the long term, recovery levels were similar after either one or two courses. 相似文献
36.
37.
Testa Rodolfo Abbiati Gianalfredo Ceserani Roberto Restelli Gianvico Vanasia Alessandro Barone Domenico Gobbi Marco Mennini Tiziana 《Pharmaceutical research》1989,6(7):571-577
A series of 21 neuroleptics with different chemical structures (phenothiazines, thioxanthenes, dibenzodiazepines, butyrophenones, benzamides, etc.) was examined for their in vitro interactions with 12 neurotransmitter binding sites in the rat brain (alpha- and beta-noradrenergic, dopaminergic, muscarinic, serotoninergic, histaminic, and opioid receptors, calcium channels, and serotonin uptake binding sites). The biochemical profile obtained from the binding data was compared with reported pharmacological and clinical profiles for this class of compounds by cluster analysis. Cluster analysis on binding data classified the compounds in three main subgroups: benzamides, compounds with an affinity mainly for DA2 and 5-HT2 receptors and inactive at muscarinic receptors, and compounds with a high affinity for alpha 1-adrenergic receptors and muscarinic receptors. The main subgroups resulting from cluster analysis of previously published pharmacological and clinical data for neuroleptics contain compounds common to the present study, with some correlations. The results extend previous observations that a complete binding profile corresponds to the pharmacological and clinical profile of this class of compounds. 相似文献
38.
39.
40.
Cedrik Tekendo‐Ngongang Sophie Dahoun Séraphin Nguefack Isabelle Moix Stefania Gimelli Huguette Zambo Michael A. Morris Frédérique Sloan‐Béna Ambroise Wonkam 《American journal of medical genetics. Part A》2020,182(4):619-622
MECP2 duplication syndrome (MDS; OMIM 300260) is an X‐linked neurodevelopmental disorder caused by nonrecurrent duplications of the Xq28 region involving the gene methyl‐CpG‐binding protein 2 (MECP2; OMIM 300005). The core phenotype of affected individuals includes infantile hypotonia, severe intellectual disability, very poor‐to‐absent speech, progressive spasticity, seizures, and recurrent infections. The condition is 100% penetrant in males, with observed variability in phenotypic expression within and between families. Features of MDS in individuals of African descent are not well known. Here, we describe a male patient from Cameroon, with MDS caused by an inherited 610 kb microduplication of Xq28 encompassing the genes MECP2, IRAK1, L1CAM, and SLC6A8. This report supplements the public data on MDS and contributes by highlighting the phenotype of this condition in affected individuals of African descent. 相似文献